Showing results (61-70 of 98) with videos related to
Sort By:
Pageof 10
Nature Biotechnology|June 25, 2013
Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escapeJerome Gilleron, William Querbes, Anja Zeigerer, et al.Nature Communications|July 27, 2022
Rare loss of function variants in the hepatokine gene INHBE protect from abdominal obesityAimee M Deaton, Aditi Dubey, Lucas D Ward, et al.Circulation Research|July 23, 2016
Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart FailureHendrik B Sager, Maarten Hulsmans, Kory J Lavine, et al.Cell Metabolism|October 3, 2019
Dietary Sugars Alter Hepatic Fatty Acid Oxidation via Transcriptional and Post-translational Modifications of Mitochondrial ProteinsSamir Softic, Jesse G Meyer, Guo-Xiao Wang, et al.Journal for Immunotherapy of Cancer|March 12, 2025
Fc-mediated immune stimulating, pro-inflammatory and antitumor effects of anti-HER2 IgE against HER2-expressing and trastuzumab-resistant tumorsMelanie Grandits, Lais C G F Palhares, Gabriel Osborn, et al.The Journal of Experimental Medicine|March 25, 2015
Macrophages retain hematopoietic stem cells in the spleen via VCAM-1Partha Dutta, Friedrich Felix Hoyer, Lubov S Grigoryeva, et al.Proceedings of the National Academy of Sciences of the United States of America|March 8, 2012
Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinomaTrevor J Grant, Joshua A Bishop, Lisa M Christadore, et al.The New England Journal of Medicine|February 7, 2019
Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent PorphyriaEliane Sardh, Pauline Harper, Manisha Balwani, et al.Circulation|April 26, 2013
Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone miceMaulik D Majmudar, Edmund J Keliher, Timo Heidt, et al.Lancet (London, England)|October 8, 2013
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trialKevin Fitzgerald, Maria Frank-Kamenetsky, Svetlana Shulga-Morskaya, et al.Pageof 10